PDA Virtual Seminars
PDA is proud to introduce a new educational benefit for members - a Virtual Seminar series. PDA plans to offer these virtual sessions on a regular basis, providing valuable education on a wide range of topics.
Members can attend these sessions right from your office or home. All you need to participate is a telephone and/or a computer with a high-speed internet connection. The audio is delivered over the telephone (toll-free) or the internet. Registrants will be provided call in/login information 2-3 days prior to the session and a URL to access the presentation right on the web in real time.
UPDATE ON BIOLOGICS
 |
Date: Time: Length: Speaker: Cost: |
March 24, 2011 5:30 - 6:30 pm (Pacific Time) 60 Minutes Bruce Strober, MD, PhD NYU School of Medicine FREE for PDA Members FREE for Residents $50 for NonMembers |
PROGRAM OVERVIEW
Appropriate therapy for the psoriasis patient requires a tailored approach. Psoriasis treatment is rapidly evolving. The data supporting the use of both old and new medications for moderate to severe psoriasis has grown rapidly, increasing the sophistication of the treatment algorithm. Further, multiple newer agents are nearing FDA approval. Finally, recent studies support the contention that severe psoriasis is a systemic disease of inflammation that increases cardiovascular risk. Therefore, through either appropriate referral or treatment selection the dermatologist may be able to help prevent comorbidities that reduce life expectancy.
LEARNING OBJECTIVES
At the conclusion of this session, the participant should be able to:
| 1) | Cite the data regarding the use of biological and conventional therapy for the treatment of psoriasis and identify certain patient scenarios whereby there may be an increased benefit by using a biologic versus conventional therapy. |
| 2) | Recognize co-morbidities that often exist in the context of psoriasis patients and develop appropriate management strategies in order to improve healthcare outcomes for your patients. |
| 3) | Review the data for contraindications in psoriasis treatment and identify clinical cases where this data applies. |
| 4) | Identify co-existing clinical states that, associated with psoriasis, may complicate the choice of effective therapy and implement therapy based on the most current evidence-based studies applicable to the specific setting. |
SPEAKER BIO
Bruce Strober, MD, PhD is an Assistant Professor, Director of the Dermatology Clinical Trials Unit and Co-Director of the Psoriasis and Psoriatic Arthritis Center at the NYU School of Medicine. His medical expertise includes General Dermatology, Psoriasis, Skin Cancer, Acne, and Eczema/Atopic Dermatitis. Dr. Strober received his medical degree from Columbia University College of Physicians & Surgeons, Medical Education. He completed his Internal Medicine Internship at NYU Medical Center; his Dermatology Residency at Bellevue Hospital; and his Dermatopharmacology clinical fellowship at Bellevue Hospital.
REGISTRATION IS FREE FOR MEMBERS & RESIDENTS!
Click here to view the recording of PDA's March 24th, 2011 Virtual Seminar.
